February

The chemo sessions began on November 1st and started with a blood draw, followed by a meeting with Page's oncologist and then continuing with the chemo infusion every week.


2/8/17

Chemo session

7:30 AM - Meeting with the chemo nurse @ UCSF for blood draw.

8:40 AM - Meeting with the chemo nurse @ UCSF for infusion #10


2/14/17

Chemo session

9:10 AM - Meeting with the chemo nurse @ UCSF for blood draw. Page's blood count remains strong.

11:00 AM - Meeting with Dr. Chien @ UCSF

12:00  PM - Meeting with the chemo nurse @ UCSF for infusion #11


2/21/17

Chemo session 

7:30  AM - Meeting with the chemo nurse @ UCSF for blood draw.

 8:30  AM - Meeting with the chemo nurse @ UCSF for infusion #12.

This is the last taxol infusion, and all went well. Now we move on to the A/C treatment.


2/23/17

MRI session

2:00 PM - MRI at UCSF - The results of this session will be given to Page's surgeon, Dr. Ewing,  to help her make her decision as to what type of surgery she will perform.  There will be one more MRI taken after the A/C treatments have concluded.

 


2/24/17

Meeting with Cheryl Ewing MD

2:20 PM - The meeting with Dr. Ewing went well today.  She says the MRI shows that the tumor has shrunk another 30% and believes that the tumor may well be gone by the end of the A/C treatment. At this point she is thinking that Page will have a lumpectomy sometime mid May (5/15 -5/17).  Page will meet with her again after the A/C treatment has completed and another MRI is performed.


2/28/17

First A/C chemo session

8:30 AM - Meeting with the chemo nurse @ UCSF for blood draw.

9:30 AM - Meeting with Dr. Chien @ UCSF

11:00  AM - Meeting with the chemo nurse @ UCSF for the A/C infusion (Adriamycin - Cyclophosphamide). The A/C infusions will be done every other week for four infusions

(A/C regimen: A chemotherapy regimen consisting of Adriamycin (doxorubicin hydrochloride) and Cyclophosphamide used in the adjuvant setting for the primary treatment of breast cancer. For more information about A/C click here.)


 

 

March